Will Herring is a Senior Director of Health Economics at RTI-HS and provides a strong interest and extensive background in mathematical modeling and decision analysis across the health care system. Since joining RTI-HS, Dr. Herring has developed an expertise in cost-effectiveness and value-based pricing modeling, and his models have been used to inform strategic decisions during the development of new health technologies and to support submissions to health care payers and regulatory agencies. Dr. Herring’s experience crosses a range of therapeutic areas, including neurology, ophthalmology, respiratory, vaccines, diabetes, liver diseases, oncology, dermatology and hematology.
Dr. Herring is a member of the International Society of Pharmacoeconomics and Outcomes Research and of the steering committee for the International Pharmaco-Economic Collaboration for Alzheimer’s Disease (IPECAD) Modelling Group, and he has presented his work at professional conferences and workshops.